← Open Payments lookup

STEFANI ALEXANDER: Open Payments

NPI 1659444933 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$904 in 52 payments from 15 companies in 2025. Trend: 2023 $1,050 · 2024 $1,074 · 2025 $904

Food & beverage: $904
CompanyPaymentsAmount
ABBVIE INC.20$201
Neurocrine BioSciences, Inc.7$159
Lundbeck LLC5$102
Vanda Pharmaceuticals Inc.3$90
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Corium, LLC2$53
Axsome Therapeutics, Inc.2$34
Supernus Pharmaceuticals, Inc.2$33
LivaNova USA, Inc.1$30
Teva Pharmaceuticals USA, Inc.1$29

Products named: VRAYLAR, INGREZZA, REXULTI, FANAPT, CAPLYTA, Azstarys, Auvelity, Qelbree.

Industry payments across TX — which companies pay providers there.